ProShare Advisors
ASTX

ProShare Advisors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

ProShare Advisors’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-93,384
Closed -$792K – 2464
2013
Q3 		$792K Buy
93,384
+15,274
+20% +$96.7K 0.02% 1050
2013
Q2 		$321K Buy
+78,110
New +$420K 0.01% 1661

ProShare Advisors's ASTX Position: Q4 2013 in Review

ProShare Advisors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 93,384 shares — an estimated $792K sold.

ProShare Advisors first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $792K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • ProShare Advisors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • ProShare Advisors sold 93,384 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $792K.
  • ProShare Advisors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • ProShare Advisors's ASTEX PHARMACEUTICALS, INC COM position peaked at $792K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on ProShare Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.